Pricing Log in Create free account

Aspira Women's Health Inc. (AWHL) vs bioAffinity Technologies, Inc. (BIAF)

Aspira Women's Health Inc. and bioAffinity Technologies, Inc. are both Diagnostics & Research companies. bioAffinity Technologies, Inc. is the larger, with a market value of $3.3M against $2.4M — 1.4× the size. Aspira Women's Health Inc. grew revenue faster over the last twelve months: −8.00% against −23.2%. Aspira Women's Health Inc. has the higher net margin (−117.1% vs −257.3%) and the higher return on invested capital (0.00% vs −408.7%). Across the 16 metrics below, Aspira Women's Health Inc. leads on 12 and bioAffinity Technologies, Inc. on 4.

Valuation

Metric AWHL BIAF Diagnostics & Research median
P/E n/m n/m 34.52
P/S 0.98 0.16 4.24
P/B n/m 0.25 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m 0.08 23.44
EV/Sales 1.16 (0.16) 5.18
Earnings yield (128.42%) (3,812.50%) (1.50%)
Free cash flow yield (56.24%) (1,223.67%) 0.00%

Profitability

Metric AWHL BIAF Diagnostics & Research median
Gross margin 58.78% 34.61% 48.32%
Operating margin (80.75%) (209.82%) (5.68%)
Net margin (117.07%) (257.33%) (4.10%)
Free cash flow margin (55.32%) (195.90%) 0.00%
Return on equity 201.29% (1,860.15%) 0.00%
Return on assets (213.58%) (245.51%) (6.05%)
Return on invested capital 0.00% (408.67%) 0.00%

Growth

Metric AWHL BIAF Diagnostics & Research median
Revenue growth (TTM) (8.00%) (23.18%) 8.99%
EPS growth (last fiscal year) 60.22% 61.55% 20.36%
Revenue growth, 5-year CAGR 14.66% — 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AWHL BIAF Diagnostics & Research median
Debt to equity (0.27) 0.15 0.01
Current ratio 0.52 1.44 2.27
Net debt to EBITDA 0.00 0.57 0.68

Dividend

Metric AWHL BIAF Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric AWHL BIAF Diagnostics & Research median
Market cap 2.44m 3.34m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack